The modified Glasgow prognostic score may predict prognostic and therapy outcomes in patients with metastatic renal cell carcinoma
Bookmark1. Baseline mGPS measures reliably predict the prognostic outcome of treatment in patients...
Read MoreJul 8, 2023
Bookmark1. Baseline mGPS measures reliably predict the prognostic outcome of treatment in patients...
Read MoreJul 8, 2023
Bookmark1. In patients with right-sided or RAS/BRAFV600E mutated tumors, the PFS was favorable...
Read MoreJul 8, 2023
Bookmark1. In a Swedish cohort, lower cardiorespiratory fitness (CRF) as measured by maximal...
Read MoreJul 2, 2023
Bookmark1. Median progression-free survival in the HSCT group was significantly longer than in the...
Read MoreJun 26, 2023
Bookmark1. In this randomized controlled trial, early integration of palliative care among...
Read MoreJun 26, 2023
Bookmark1 .Progression-free survival is improved in patients receiving fulvestrant-capivasertib...
Read MoreJun 26, 2023
Bookmark1. Patients who were randomized to neoadjuvant FOLFOX vs standard chemoradiation had...
Read MoreJun 23, 2023
Bookmark1. In this clinical decision support study, the performance of the Chat Generative...
Read MoreJun 20, 2023
Bookmark1. This study found that healthcare disruption during the COVID-19 pandemic led to...
Read MoreJun 20, 2023
Patients with IBD and subtotal colectomy experienced a higher risk for rectal cancer compared with...
Read MoreJun 19, 2023
Bookmark1. The 5-year overall survival had a hazard ratio of 0.49, and this benefit was generally...
Read MoreJun 14, 2023
Bookmark1. Progression-free survival was greater in the trastuzumab group compared to standard...
Read MoreJun 14, 2023
Bookmark1. Median overall survival was greater in the pembrolizumab group compared to the control...
Read MoreJun 10, 2023
Incorporating HPV vaccination into PrEP services may increase the number of patients who receive...
Read MoreJun 8, 2023
The GeparNuevo trial sheds light on the role of RNA expression from peripheral immune cells in...
Read MoreJun 3, 2023
Bookmark1. The addition of olanzapine to standard antiemetic therapy had a significantly higher...
Read MoreJun 2, 2023
Bookmark1. Median progression-free survival in zolbetuximab group was greater than in the placebo...
Read MoreJun 2, 2023
Bookmark1. Surgical removal of the tonsils and adenoids was associated with slightly increased...
Read MoreMay 29, 2023
BookmarkEvidence rating level: 3 (Average) 1. Exposure to a higher cumulative number of pediatric...
Read MoreMay 27, 2023
Bookmark1. Overall survival in the quizartinib group was 31.9 months compared to 15.1 months in...
Read More